RS50673B - Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smeše r- i s-citaloprama - Google Patents

Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smeše r- i s-citaloprama

Info

Publication number
RS50673B
RS50673B YUP-1014/03A YUP101403A RS50673B RS 50673 B RS50673 B RS 50673B YU P101403 A YUP101403 A YU P101403A RS 50673 B RS50673 B RS 50673B
Authority
RS
Serbia
Prior art keywords
citalopram
acid addition
addition salt
racemic
optionally
Prior art date
Application number
YUP-1014/03A
Other languages
English (en)
Inventor
Rikke Eva Humble
Troels Volsgaard Christensen
Michael Harold Rock
Ole Nielsen
Hans Petersen
Robert J.M. Dancer
Original Assignee
H. Lundbeck A/S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S. filed Critical H. Lundbeck A/S.
Publication of RS101403A publication Critical patent/RS101403A/sr
Publication of RS50673B publication Critical patent/RS50673B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Postupak za pripremanje recemske citalopram slobodne baze ili od toga nastale kisele adicione soli i/ili R-i S-citaloprama kao slobodne baze ili od toga nastale kisele adicione soli separacijom smeše R- i S-citaloprama/sa više od 50% jednog od enantiomera u frakciju koja sadrži racemski citalopram i/ili frakciju S-citaloprama ili R-citaloprama, naznačen time, štoi) se citalopram istaloži iz rastvarača kao slobodna baza ili od nje nastala kisela adiciona so;ii) se formirani talog odvaja iz matične tečnosti;iia) ako je talog kristalan opciono se rekristališe jednom ili više puta da se formira racemski citalopram, i onda se opciono pretvara u od toga nastalu kiselu adicionu so;iib) ako talog nije kristalan, koraci i) i II) se opciono ponavljaju sve dok se ne dobije kristalni talog i kristalni talog se opciono jednom ili više puta rekristališe da formira racemski citalopram, i onda se opciono pretvara u od toga nasalu kiselu adicionu so;iii) se matična tečnost opciono podvrgava daljem prečišćavanju i S-citalopram ili R-citalopram se izoluju iz matične tečnosti i opciono pretvaraju u od toga nastalu kiselu adicionu so. Prijava sadrži još 18 patentnih zahteva.
YUP-1014/03A 2001-06-25 2002-06-25 Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smeše r- i s-citaloprama RS50673B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100991 2001-06-25
PCT/DK2002/000426 WO2003000672A1 (en) 2001-06-25 2002-06-25 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram

Publications (2)

Publication Number Publication Date
RS101403A RS101403A (en) 2007-02-05
RS50673B true RS50673B (sr) 2010-06-30

Family

ID=8160584

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-1014/03A RS50673B (sr) 2001-06-25 2002-06-25 Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smeše r- i s-citaloprama

Country Status (40)

Country Link
US (1) US7112686B2 (sr)
EP (1) EP1412341B1 (sr)
JP (2) JP4377219B2 (sr)
KR (4) KR100902530B1 (sr)
CN (2) CN101440079B (sr)
AR (2) AR034612A1 (sr)
AT (1) ATE284395T1 (sr)
BG (1) BG66372B1 (sr)
BR (1) BRPI0210574B8 (sr)
CA (2) CA2691149C (sr)
CO (1) CO5550420A2 (sr)
CZ (1) CZ305034B6 (sr)
DE (1) DE60202216T2 (sr)
DK (1) DK1412341T3 (sr)
EA (1) EA006446B1 (sr)
ES (1) ES2233834T3 (sr)
HK (2) HK1068627A1 (sr)
HR (1) HRP20031075B1 (sr)
HU (1) HU228476B1 (sr)
IL (1) IL159229A0 (sr)
IS (1) IS2426B (sr)
JO (1) JO2389B1 (sr)
MA (1) MA26260A1 (sr)
ME (2) ME00027B (sr)
MX (1) MXPA03011770A (sr)
MY (1) MY133471A (sr)
NO (2) NO329873B1 (sr)
NZ (1) NZ530104A (sr)
PE (1) PE20030122A1 (sr)
PL (1) PL366560A1 (sr)
PT (1) PT1412341E (sr)
RS (1) RS50673B (sr)
SI (1) SI1412341T1 (sr)
SK (1) SK287696B6 (sr)
TN (1) TNSN02062A1 (sr)
TW (1) TWI236473B (sr)
UA (1) UA75147C2 (sr)
UY (2) UY27356A1 (sr)
WO (1) WO2003000672A1 (sr)
ZA (1) ZA200309633B (sr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040991A1 (es) 2002-08-12 2004-12-27 Lundbeck & Co As H Separacion de intermediarios para la preparacion de escitalopram
CN100334071C (zh) * 2002-12-23 2007-08-29 H·隆德贝克有限公司 外消旋西酞普兰二醇和 /或 s -或 r-西酞普兰二醇的制备方法及这些二醇在制备外消旋西酞普兰二醇、 r -西酞普兰和 /或 s -西酞普兰中的用途
WO2004056754A1 (en) 2002-12-23 2004-07-08 H. Lundbeck A/S A process for the preparation of racemic citalopram diol and/or s- or r- citalopram diols and the use of such diols for the preparation of racemic citalopram, r-citalopram and/or s-citalopram
CA2511142A1 (en) 2002-12-23 2004-07-08 H. Lundbeck A/S Escitalopram hydrobromide and a method for the preparation thereof
TR200504022T1 (tr) * 2003-03-24 2006-08-21 Hetero Drugs Limited (S)-sitalopram oksalatın yeni sıvı kristal formları.
CN100569765C (zh) 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050196453A1 (en) 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
CA2558198A1 (en) * 2004-03-05 2005-09-15 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
ITMI20040717A1 (it) 2004-04-09 2004-07-09 Adorkem Technology Spa Procedimento chemo-enzimatico per la preparazione dell'escitalopram
JP2006008603A (ja) * 2004-06-25 2006-01-12 Sumitomo Chemical Co Ltd 光学活性シタロプラムの製造方法、その中間体およびその製造方法
EP2141156A1 (en) * 2004-08-23 2010-01-06 Sun Pharma Global FZE Process for Preparation of Citalopram and Enantiomers
US7989645B2 (en) * 2004-08-23 2011-08-02 Sun Pharma Global Fze Process for preparation of citalopram and enantiomers
EP1901714A2 (en) * 2005-05-20 2008-03-26 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
WO2007053796A2 (en) 2005-10-14 2007-05-10 Forest Laboratories, Inc. Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
FI121570B (fi) 2007-09-11 2011-01-14 Lundbeck & Co As H Menetelmä essitalopraamin valmistamiseksi
US8022232B2 (en) 2007-09-11 2011-09-20 H. Lundbeck A/S Method for manufacture of escitalopram
CN100548974C (zh) * 2007-10-11 2009-10-14 浙江大学 西酞普兰中间体的萃取分离方法
CN101560199B (zh) * 2008-04-16 2013-09-18 北京德众万全药物技术开发有限公司 一种依地普仑的制备方法
TWI381813B (zh) 2010-01-12 2013-01-11 Taiwan Paiho Ltd A Velcro assembly for a foamed article and a foamed article comprising the adhesive tape assembly

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
TR200401456T1 (tr) * 1999-10-25 2005-04-21 H. Lundbeck A/S Sitalopram hazırlanması için yöntem.

Also Published As

Publication number Publication date
ATE284395T1 (de) 2004-12-15
US20040259940A1 (en) 2004-12-23
JP2004536093A (ja) 2004-12-02
HU228476B1 (en) 2013-03-28
CA2450890C (en) 2011-02-15
CO5550420A2 (es) 2005-08-31
BG108532A (bg) 2005-04-30
SK512004A3 (en) 2004-05-04
RS101403A (en) 2007-02-05
AR034612A1 (es) 2004-03-03
NZ530104A (en) 2006-08-31
KR20080100498A (ko) 2008-11-18
HK1068627A1 (en) 2005-04-29
HK1132729A1 (en) 2010-03-05
UY27356A1 (es) 2003-01-31
CA2450890A1 (en) 2003-01-03
CN1520405A (zh) 2004-08-11
MEP1508A (xx) 2010-02-10
HUP0400293A3 (en) 2007-05-29
ME00027B (me) 2010-02-10
BR0210574B1 (pt) 2014-03-04
AU2002344948B2 (en) 2007-08-16
TWI236473B (en) 2005-07-21
SK287696B6 (sk) 2011-06-06
DE60202216D1 (de) 2005-01-13
CA2691149C (en) 2011-09-13
UA75147C2 (en) 2006-03-15
KR20040030702A (ko) 2004-04-09
HUP0400293A2 (hu) 2004-09-28
IS2426B (is) 2008-10-15
NO20101420L (no) 2003-12-18
US7112686B2 (en) 2006-09-26
CZ2004131A3 (cs) 2004-04-14
JP2009203233A (ja) 2009-09-10
CN101440079A (zh) 2009-05-27
BRPI0210574B8 (pt) 2021-05-25
DK1412341T3 (da) 2005-04-04
HRP20031075B1 (en) 2011-12-31
BG66372B1 (bg) 2013-10-31
NO335106B1 (no) 2014-09-15
IS7068A (is) 2003-12-08
TNSN02062A1 (en) 2005-12-23
NO329873B1 (no) 2011-01-17
PT1412341E (pt) 2005-04-29
WO2003000672A1 (en) 2003-01-03
KR100902530B1 (ko) 2009-06-15
DE60202216T2 (de) 2005-12-08
NO20035671D0 (no) 2003-12-18
KR20090031958A (ko) 2009-03-30
PL366560A1 (en) 2005-02-07
MY133471A (en) 2007-11-30
CZ305034B6 (cs) 2015-04-08
EP1412341B1 (en) 2004-12-08
EP1412341A1 (en) 2004-04-28
UY35850A (es) 2016-06-30
PE20030122A1 (es) 2003-02-12
BR0210574A (pt) 2004-08-03
CN101440079B (zh) 2011-05-25
KR100939945B1 (ko) 2010-02-04
AR083483A2 (es) 2013-02-27
IL159229A0 (en) 2004-06-01
HRP20031075A2 (en) 2004-04-30
JO2389B1 (en) 2007-06-17
ZA200309633B (en) 2005-02-23
JP4377219B2 (ja) 2009-12-02
KR20100052550A (ko) 2010-05-19
CA2691149A1 (en) 2003-01-03
CN100429208C (zh) 2008-10-29
SI1412341T1 (en) 2005-04-30
JP5064436B2 (ja) 2012-10-31
MA26260A1 (fr) 2004-09-01
ES2233834T3 (es) 2005-06-16
MXPA03011770A (es) 2004-04-02
NO20035671L (no) 2003-12-18
EA200400082A1 (ru) 2004-06-24
EA006446B1 (ru) 2005-12-29

Similar Documents

Publication Publication Date Title
RS50673B (sr) Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smeše r- i s-citaloprama
SE0103046L (sv) Kristallin bas av citalopram
ID19108A (id) Proses produksi asam tereftalat (pecahan dari p-002451)
IS7947A (is) Aðferð til að framleiða kristölluð form ljósfræðilegra handhverfa módafíníls
SU508192A3 (ru) Способ получени -(метоксиметил-фурилметил)-6,7-бензоморфанов или -морфинанов
EA200200016A1 (ru) Способ получения чистого циталопрама
ATE445621T1 (de) Racemisierung und enantiomerentrennung von clopidogrel
ATE19394T1 (de) Verfahren zur herstellung von cyclopropancarbonsaeureesterderivaten.
CA2135169A1 (en) Process for stereospecific hydrolysis of piperidinedione derivatives
US4515961A (en) Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4,-b] indole-1-acetic acid using enrichment crystallization
ES8100237A1 (es) Procedimiento para la separacion de los dos isomeros opticos del moprolol
UA84859C2 (ru) Способ получения свободной основы и/или кислотно-аддитивной соли рацемического циталопрамдиола и/или свободной основы и/или кислотно-аддитивной соли r- или s-циталопрамдиола
DK123089A (da) Fremgangsmaade til adskillese af alpha-l-asparagyl-l-phenylalaninmethylester fra en oploesning
WO2005012278A3 (en) Process for purifying citalopram using polybasic acids
EA200401417A1 (ru) Новые производные пиперидинилалкиламинопиридазинона, способ их получения и содержащие их фармацевтические композиции
IE40218B1 (en) Process for recovering phenylalkylamines
HRPK20070454B3 (en) A process for the preparation of racemic citalopram diol and/or s- or r- citalopram diols and the use of such diols for the preparation of racemic citalopram, r-citalopram and/or s-citalopram
JPS5527166A (en) Production of optically active cyclamen aldehyde
KR910009689A (ko) 신규 셀레노펜 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR830004190A (ko) 시클로프로판 카르복실산 에스테르 유도체의 제조방법
YU60790A (sh) Postupak za dobijanje 5-fenilpirimidin jedinjenja i njihovih soli
JPS56131576A (en) Novel phenylacetamide derivative
DK1504021T3 (da) Fremgangsmåde til dehydrogenering af azaandrostanforbindelser
GB1428938A (en) 2,5-dideoxystrptamines and 6,6-diaza-2,4-dihydroxy-bicyclo- 3,2,1-octanes and methods for their preparation